19th. May, 2021 (alternative date: 30st September, 2021.)
Welcome to Digital Health Summit
Prof. Miklós Kásler, MD, Ph.D
Minister of Human Resources
Prof. Ildikó Horváth, MD., Ph.D.
State Secretary for Health
Mauricio Campos Suarez
CEE Digital Lead
The 1st Digital Health Summit was February 27th, 2020. We had around 400 guests and 31 journalist attended.
The Digital Health Summit brings together public and private health care, digital pharma, and manufacturers of digital medical products, venture capitalists ynd startups from around Hungary, to network, exchange ideas and to become more familiar with opportunities in Hungary. Our independent conference will become a significant event for many companies in the DH industry and is particularly important in Hungary given the explosion of business and entrepreneurship in the region.
Digital health is the convergence of digital technologies with health, healthcare, living, and society to enhance the efficiency of healthcare delivery and make medicines more personalized and precise. The discipline involves the use of information and communication technologies to help address the health problems and challenges faced by people under treatment. These technologies include both hardware and software solutions and services, including telemedicine, web-based analysis, email, mobile phones and applications, text messages, wearable devices, and clinic or remote monitoring sensors. Generally, digital health is concerned about the development of interconnected health systems to improve the use of computational technologies, smart devices, computational analysis techniques, and communication media to aid healthcare professionals and their clients manage illnesses and health risks, as well as promote health and wellbeing.
Digital health is a multi-disciplinary domain involving many stakeholders, including clinicians, researchers and scientists with a wide range of expertise in healthcare, engineering, social sciences, public health, health economics and data management.
INSPIRED. Our speakers are leading real business transformation, driving change across the enterprise and actioning measurable digital innovation for their businesses. Get motivated from leaders and walk away with new ideas you can implement.
CHALLENGED. Rethink your current processes and business blueprints, the event speakers will challenge your way of thinking and allow you to realise that new methods may be your best way of moving forward sitting alongside your current beliefs.
TRANSFORMED. The conference agenda and speakers are put together as such to reveal insights into how some of the biggest organisations are going about digital, from real business use cases to success stories and where the challenges may lie.
MEET LIKE MINDED PEERS
NETWORKING. It's an invaluable part of events and where real value often presents itself, meeting those who are facing the same challenges and coming together to solve similar issues. Our agendas feature numerous opportunities throughout the day to meet like minded folk from various industries and backgrounds. We have previously had extremely positive feedback from delegates who have found long lasted business relationships with those who they wouldn't normally meet from opposite industries and largely seeking out the same solutions to industry wide transformation sticking points.
Concert Hall (ground floor)
keynote: Prof. Miklós Kásler, MD, PhD, Minister of Human Resources, Hungary presentation
keynote: Pharma Ecosystem Innovation: Value proposition & real life experience - Top 3 highlights and learnings from running open innovation for pharma + to bring some insights/outside-in perspective from The Wide lens theory + Novartis BIOME CEE plans + what we could propose to start today to collaborate with Hungary Startups ecosystem - Mauricio Campos Suarez (Novartis AG)
Keynote: Alexander Klein (Group Leader Digital Health F. Hoffmann - La Roche) presentation
keynote: Abundant funding to boost research, development and innovation in Hungary - In terms of innovation performance, Hungary is a moderate innovator in the EU, but we aspire to be among the leaders by the end of the decade. According to the latest data from the Hungarian Central Statistical Office, domestic expenditure on research and development has been rising for years, reaching an unprecedented HUF 702 billion in 2019, which is more than double of the 2010 expenditure. Medical sciences and health industry are traditionally outstanding in the Hungarian RDI landscape, but contributions from this sector are even more appreciated due to the coronavirus pandemic crisis. Government funding to foster research, development and innovation sees a significant increase also this year: over HUF 160 billion will be spent from national funds, while the new EU financed operational program will bring further calls worth several hundred billion HUF for the Hungarian RDI ecosystem, just in 2021 alone. - Dr. Zoltán Birkner (National Research, Development and Innovation Office)
keynote: Latest news of digital health development - By the development and nationwide introduction of the National eHealth Infrastructure, Hungary is leading the way in laying the foundation of a digital healthcare system. In terms of digital public services, this infrastructure is still one of Europe’s best. In November 2017, Hungary introduced an accessible and effective digital infrastructure that provides major developments for the domestic healthcare system. Digital solutions and telemedicine both have huge potential for our future society, as the structured collection, storage and lawful utilization of healthcare data represents a significant value. Today the National eHealth Infrastructure (EESZT), operated by the National Healthcare Service Center, is an integral part of healthcare and diagnostic work and is used by physicians and patients as well. - Bálint Szabó (National Healthcare Service Center)
New medical technology solutions in remote patient management - Diabetes mellitus is responsible for a huge burden of disease all over the world, including Hungary, as well. Diabetes is associated with an increased risk of numerous serious complications and comorbidities, although the risk is reduced if diabetes is well controlled. Diabetes imposes an increasing economic burden on each country healthcare system especially due to the treatment of complications. Remote monitoring is not the future any more. Remote monitoring is a clinically proven solution that improves therapy outcomes and follow-up efficiency, while not compromising on safety. - Zoltán Melicher and Csaba Varga, MD (Medtronic Hungary)
Telemedicine with utilization of BigData: COVID applications - The unique insights accessed through BigData are already utilized by healthcare professionals in several disease areas to optimize therapy efficiency and drug adherence. Since the beginning of the pandemic, the potential of telemedicine and BigData are increasingly recognised by decision makers. In times when doctor-patient interactions are limited, the value of monitoring patients' health status remotely via smart devices has significantly increased. How do you utilise a telemedicine infrastructure to gain insights on coronavirus while keeping you patients safe? - Fruzsina Mezei and Rudolf Mezei (Omron Medistance)
Digital development in Hungary’s health care and health industry: building a digital ecosystem. The role of digitalization: improvement and protection of public health care. What are some of the problems in public health care that can be solved by digitalization? What has been solved already and what still needs to be done? - Tibor Gulyás (Ministry of Innovation and Technology), Prof. Ildikó Horváth, MD., Ph.D. (Ministry of Human Capacities), Bálint Szabó (OKFŐ), - Moderator: Hatem Lemia (Novartis Hungary)
Digital, Channel & Tech Innovations In Times Of Change: Keep up with business-critical innovation and tech adoption trends. A Look Forward To 2021 & The Future Of Pharma: How has the face of pharma changed, is it embedded and what must we prepare for now? - Pharma Digital panel discussion - (MSD) and (Richter Gedeon), Moderator: Zoltán Novák, Ph.D. (TaylorWessing)
Digitalization in the private clinics - panel discussion - Anna Balázs, MD (Déli Klinika)
Hungarian telemedicine trends in 2020 during COVID - Telemedicine allows health care professionals to evaluate, diagnose and treat patients at a distance using telecommunications technology. As part of the measure related to the epidemiological situation, Decree No 157 of 29 April 2020 was published in the Magyar Közlöny. One of the most important points of the Government Decree is that the personal presence of the patient is not a condition for the provision and financing of the health care service, if the nature of the healthcare and the medical judgment allow it. The use of telemedicine due to the situation became a daily practice for both GPs and specialists in Hungary, and this trend does not reverse. We initiated a representative research by interviewing 600 doctors from 15 specializations to explore their impressions, the pros and cons of telemedicine, and how it can improve the quality of patient care. - Balázs Kertész (Szinapszis)
Library (first floor)
A roundtable of Israeli digital health startups - Alon Kushnir (RedDress), Eyal Copitt (Cardiacsense), Jordan Rubinson (PulseNmore) - Moderator: Szabolcs Szolnoki (Science and Tech Diplomat of Hungary in Tel Aviv)
A roundtable of Hungarian digital health startups - Moderator:
Venture Capital in the health industry - Gergely Szűcs, Ph.D. (Cashline Investments) - Moderator: Albert Zita (Cerha Hempel)
Put Patients At The Heart Of Your Strategy: Easy-to-use platforms, action-driven strategies and customer-centric comms to boost patient engagement today - Pharma Digital panel discussion - Irma Veberic (Roche Hungary) and Roland Kreissig, MD (Novartis Hungary) - Moderator: József Bulcsú Fenyvesi LL.M. (Oppenheim)
Digital Therapy Planning in Precision Oncology - Every patients’ tumor harbors an individual combination of 4-5 mutations out of 6 million potential mutations of 600 genes. There are already 100 targeted therapies in clinical use, and there are around 1000 in clinical development. The challenge of precision oncology is to choose which mutant gene to target with which targeted therapy to achieve response in the presence of the specific mutation and the presence of all the other mutant genes. The solution to this problem is the help of artificial intelligence. This new software that guides therapeutic decisions belongs to a new medical device class called „digital therapeutics .” Digital therapy planning can potentially increase the efficacy and cost-efficacy of precision oncology. - István Peták, MD, Ph.D. (Oncompass)
Remote patient follow-up - Péter Becságh, Ph.D. (Roche), Zoltán Melicher (Medtronic Hungary), Barnabás Szabó (77 Elektronika) - Moderator:
Digital health solutions in the pandemic management - Miklós Szócska, MD, PhD (Semmelweis University Institute of Digital Health Sciences)
Workshop room (3rd floor)
Roche Workshop - Master of ceremonie: Ádám Kupán (Roche Hungary)
Novartis Digital Health Startup Competition - 6X8 mins Startup Pitch, discussion with the jury, award ceremony- Juries: Otto Albrecht (Cashline Investments), (Hiventures), Krisztián Kölkedi (NKFIH), (Novartis Hungaria) - Master of ceremonies:
Networking room (2nd floor)
Coffee, sandwich, networking, meeting room
Zita is M&A partner of CERHA HEMPEL Dezső & Partners Law Firm, with over 16 years of experience in m&a transactions. She has extensive experience in advising on complex domestic and cross border M&A transactions in a wide range of business sectors, including health care. She has led a number of transactions in the health care sector in the past years representing either joint ventures, private equity firms or international healthcare providers.
We in a Healthcare Innovation team work together to identify and incubate ideas around personalised Health Care concepts. Originally I graduated as a Biotechnologist and I did my PhD from Molecular Pathology. I had a possibility to join for some years to a research group in Austria and also in Germany to study the molecular background of Atherosclerotic lesions.
Prof. Benyó received his Ph.D. degree from BME in 1998 and Dr. habil in 2013. He received Candidate of Science degree from the Hungarian Academy of Sciences in 1998. Between 1998 and 2008 Prof. Benyó was working at the Department of Informatics, Széchenyi István University, Győr where he was the Vice Dean of International and Scientific Affairs and Secretary of the Multidisciplinary Doctoral School of Faculty of Engineering Sciences between 2005 and 2006. Prof Benyó's Selected Major Honours, Awards, Invited Positions and Fellowships: Adjunct Professor/Adjunct Associate Professor (Reader) University of Canterbury, Department of Mechanical Engineering, Christchurch, NZ (2020 / 2013); Eötvös Fellow (by State of Hungary, 2007); “Outstanding creator of the year” (For Technical Development of the Industry Found, 2002); Békésy György Post-doctoral Fellow (by Hungarian Academy of Sciences, 2001); Bolyai János Research Fellow (by Hungarian Academy of Sciences, 1998); Soros Short Fellow (Soros Foundation, 1993); Invited Guest Editor of three Special Issues of biomedical engineering journals (Journal of Biological Signal Processing and Control, Control Engineering Practice); Co-Chair of International Federation on Automatic Control (IFAC) Technical Committee 8.2 Biological and Medical Systems. His research interest includes, among others, the modelling and control of physiological systems, model based medical diagnostic and treatment solutions, metabolic control; Nuclear medical imaging, image reconstruction algorithms, parallel implementation of SPECT reconstruction in GPGPU platform; Medical image processing, fuzzy methods, image based medical diagnostics, medical informatics; Mobile and contactless technologies (including Near Field Communication Technology) to create novel technological solutions and services, system security, safety critical solutions. Prof Benyó is the leader of the Biomedical Engineering Laboratory at the Department of Control Engineering and Information Technology working in theoretical and applied research in biomedical engineering and medical informatics for 15+ years. The Laboratory provides the basic infrastructure for Biomedical Engineering training at the Faculty of Electrical Engineering and Informatics. Prof Benyo is the leader and/or participant of several successful OTKA (Hungarian Scientific Research Fund), EU financed national (GVOP) and international (Copernicus, FP6, FP7, H2020) projects, and is coordinator of the DCPM: Digital Clone for Personalized Medicine (EU H2020-MSCA-RISE-2018 call, Grant ID: 872488). Prof. Balázs Benyó has published more than 350 scientific publications, received more than 1800 references, his h-index is 21.
His professional career demonstrates thorough experience in higher education as a lecturer and education organiser, in scientific life as a researcher of innovation management, and in the business sector as a manager dealing with organisational and business development and industrial research and development projects.
Over the past 20 years, Eyal Copitt’s professional experience has focused on international business and technology covering multiple disciplines, including satellites, data storage, bandwidth optimization and in the last years in pharma and medical devices. His management success is a function of his sharp analytical skills, long-term vision, and expertise in Go-to-Market strategy planning.
Belgyógyász – Kardiológus, nemzetközileg jegyzett szívritmuszavar specialista. Általános orvosi diplomáját a Semmelweis Egyetemen szerezte, majd a szakképzése után 2005 és 2010 között a Frankfurti Egyetem Kardiológiai Klinikáján dolgozott, ahol a szívritmuszavar részleg főorvosaként dolgozott. Európai Kardiológus diplomát szerzett, majd az Európai Kardiológus Társaság tiszteletbeli tagjának választotta. A Semmelweis Egyetemen szerezte PhD doktori (2009) címét, Egészségügyi Menedzser MSc diplomáját (2019), majd ugyanitt habilitált (2020). A Magyar Kardiológusok Társasága Aritmia és Pacemaker munkacsoport alelnöke. Kutatási érdeklődési köre a szívritmuszavar, valamint szívelégtelenség miatt eszközös kezelésre szoruló betegek ellátási módszerei, a katéteres, műtéti (pacemaker, defibrillátor), valamint gyógyszeres kezelési stratégiái. Bevezette Magyarországra a legmodernebb, teljesen a szívbe ültethető törpe pacemaker (Micra) alkalmazását, és tapasztalataival nagymértékben hozzájárult a technológia széleskörű elterjesztéséhez. A mindennapi betegellátás mellett fontos számára az eszköz- és gyógyszergyártókkal való szoros együttműködés, a diagnosztikus és terápiás eljárások kifejlesztésével és alkalmazásával kapcsolatos kutatómunka.
Graduated from the Janus Pannonius University of Pécs in 1998 and pursued postgraduate studies in EU law at the University of Pécs. Obtained an LLM in International Economic Law at the University of Warwick in 2004. Attended the University of Oxford as a Chevening scholar and received a Magister Juris degree in 2006. Joined the Budapest office of Freshfields Bruckhaus Deringer in 2005. Associate of Oppenheim since 2007, partner at the firm since 2010. Head of the Corporate practice of Oppenheim since 2014.
Areas of specialization: Company Law, M&A, Capital MarketTransactions.
Sector experience: Capital markets, Chemicals & Pharma
Languages: Hungarian and English
Innovation of the Ministry of Innovation and Technology
As the Deputy State Secretary for Innovation of the Ministry of Innovation and Technology, I am responsible for the development of the Hungarian innovation ecosystem. I carry out this mission with the conviction that the knowledge base of Hungarian researchers and the talent of the next generation provides an indispensable opportunity for Hungary. The efficient use of these resources must be increased for the success of society and the economy. The recent period has proven that our work vitalizes and strengthens the organizations and other actors of the R&D and innovation field.
In my entire life, I pay undivided attention to the analysis of social, political, and economic trends.
Balázs has an MA in Economics and works for Szinapszis from the beginning as the professional leader of researches, also responsible for internal innovation and international relationships. Balázs is a developer Szinapszis’ branded pharmaceutical solutions and research models. Main research areas: sales force effectiveness, pharmaceutical targeting, segmentation, KOL mapping, price sensitivity tests, MCM and digital transition in the pharma industry. Presenter on various Hungarian and International conferences, member end representative of Szinapszis in the European market research associations (ESOMAR, EphMRA).
After dealing with own startups he got involved in business development, then carried on as an organization development coach and top management adviser. Currently he is engaged in launching innovation services for the Hungarian ecosystem, which includes a mission to boost youth and startup programs. Created with his supervision, the Hungarian Startup University Program now plays a key role in promoting entrepreneurship and innovative mindset among Hungarian university students.
Óbuda University (Hungary)
Dr. Miklos KOZLOVSZKY is a full Professor at Óbuda University (Hungary), head of the BioTech Research Center (BTRC) and the John von Neumann Faculty of Informatics, besides that he is working as Senior Research Fellow at the Laboratory of Parallel and Distributed Systems in the Computer and Automation Research Institute of the Hungarian Academy of Sciences. He is full professor (since 2020) and received his habilitation (in 2017) at Óbuda University. He received his PhD from the Budapest University of Technology and Economics (Hungary) in 2009, and his MSc in Computer Science from the University of Szeged (Hungary) in 2001. He is a lecturer at various Universities: at Óbuda University (Hungary) since 2005, at Semmelweis University (Hungary) since 2015 and at National University of the Litoral (Santa Fe, Argentina) since 2017. Before that, he was working: as researcher in the Bioinformatics Group at IMP /Research Institute of Molecular Pathology/ (Austria), at CERN /European Organization for Nuclear Research/ (Switzerland), and as team leader at Vodafone Hungary (Hungary). During last 20 years he was involved in many EU FP6, FP7 (SHIWA, HP-SEE, SEE-GRID-SCI, EGEE, EGI, …) and H2020 projects at various positions (deputy project leader, WP leader, engineer, etc.). He is author and co-author of 180+ research articles in peer-reviewed journals and books.
He is currently a General Manager for Novartis Oncology responsible for a cluster of 15 countries in Central Eastern Europe. Roland is a physician by background but switched his career from academic medicine to working as a consultant at McKinsey before joining Novartis in 2004. At Novartis, Roland has been working in various leadership roles across geographies, in the US, in Europe, and in Global roles, and across different functions with a focus in Marketing, Sales, Strategy, and General Management.
Entrepreneur and founder of several successful medical device startups for the past 22 years. He is the founder and CEO of RedDress ltd, leading it from an idea a to successful commercialization around the world. Earned two BAs with honor in computer science and life science from Bar Ilan university, Israel. He led the design and conduct of over 60 clinical studies in North America, Asia, Europe and Africa and has 16 medical patents in various fields, including pulmonology, cardiology, interventional cardiology, urology, dermatology and Gynecology.
Lemia is an economist, graduated from Corvinus University of Budapest. After a short time spent in FMCG (Unilever) she immediately jumped into the world of pharmaceuticals where she’s been since 11 years now. After several roles in Communications and Public Affairs at Sanofi where she also spent a year in Sofia, Bulgaria; she joined MSD as Policy and Communications Lead where she was heavily involved in shaping public discussions around HPV vaccination and lung cancer. She is currently heading Public Affairs, Communications and Advocacy at Novartis Hungary. Lemia is passionate about public health issues, especially addressing health literacy & education and she’s a strong believer in the change civil society and patient advocates could make.
As a Health Policy Expert of the Hungarian National Public Health Centre since 2017, Fruzsi is strategically planning and implementing evidence-based developments in the field of primary care. She is currently working on improving care of six chronic disease groups that are leading causes of death in Hungary (e.g. hypertension, diabetes, oncological diseases etc.). She graduated as a Medical Anthropologist from Durham University in 2017 and received her MSc in Health Policy, Planning and Financing from ELTE in 2019. Stemming from her research background, she is an advocate of evidence-based policy making and aims to disseminate the idea of data collection and analytics to systematically address leading health issues. Working on national and international health care projects, primarily in the field of chronic care, she has first-hand experience in the barriers of implementing innovative digital solutions in the public health sphere. She works to overcome these barriers.
Since 1991 he has been leading the Hungarian brand representation, sales and development center of the Japanese-based OMRON Healthcare Division. For nearly three decades, he has conducted and implemented prevention, research and development programs that determine the qualitative hypertension, health, and chronic disease prevention, making digital blood pressure monitoring and international practice based on it accessible to everyone at home, as well as providing the education of same. In 2010, he developed, tested and marketed the first service product category, value chain, and partner network to create large data assets related to digitalized health status, which product is recently entering the market abroad, in strategic cooperation with foreign and domestic partners. He was the first to launch a health monitoring service based on the quality-assured, certified, IoT connected device structure and digital medicine data processing method for domestic health care providers and pharmaceutical industry stakeholders. He graduated in 1983 from the College of Foreign Trade and later in 2012 got degree in economics, specialized in healthcare management from Corvinus University. Together with his colleagues, he became committed to the strategic planning, research and modeling of the future of domestic health prevention, resources and predictive setups in domestic and international projects, expert’s and IT professional programs, and received his qualification in this field at Eötvös Loránd University Health Politics MSc. degree in 2019. Under his leadership, several domestic and foreign programs are underway to systematize digitized markers of chronic illness health conditions, organize them into big data assets, data mining, as well as develop related artificial intelligent algorithm systems, predictive analytical modeling of health status data, and integration into business applications via standard platform. As a publisher of numerous lectures, articles and on-line entries, he aims to modernize domestic health prevention based on digitalized data, to prepare the decision-makers, medical professionals, and the public to appreciate, receive and use digital data-based healthcare.
Rita Molnar earned her BA business communication degree in the Budapest College of Communication and Business in 2008. She completed her MBA master program at Budapest Metropolitan University in 2020 and she is now pursuing a Health Policy, Planning and Financing Master’s program at Budapest Corvinus University. The program is designed to provide you with a comprehensive understanding of the complexities of health care systems both at macro- and micro-levels within the context of technological development, an ageing population and patient expectations. She will be well-prepared to work in health administration, government departments, research and consultancy agencies, universities, national health services, health care organizations and pharmaceutical and medical device industry.
She started her career as a professional photojournalist from 1997 to 2002. Rita was just 21 when she started organizing events, and she founded her own company. Her first event was an amateur film festival in Eger in 1998. Ever since, she has been organizing 2 conferences per year, mainly in the medical, VC investing and banking fields. Between 2001-2005 Rita also worked as a movie producer. She was involved in co-producing a movie directed by the iconic Magyar movie-maker Miklós Jancsó. From 2006 to late 2007 Rita managed the event marketing team at Ringier Publishing, a Hungarian subsidiary of a Swiss-based leading publishing firm. In the summer of 2010 Rita founded Slimexpo with a venture capital involvement, and she organized with her own team a Slimexpo Festival with a diet, health and beauty theme at a premium event venue in Budapest Aréna in the spring of 2011.
Zoltán obtained his law degree in 2009 from the University of Debrecen. He also studied in Tübingen, Leuven and Amsterdam. He holds an LL.M in International Dispute Resolution from Queen Mary University in London and defended his PhD in 2011. In 2014, he successfully passed the bar exam.
He acquired his first professional experiences in the German Federal Parliament. In 2010 he started his career as a lawyer. Since 2018, he has been a partner at Taylor Wessing Budapest.
He specializes in pharmaceutical law, intellectual property law and dispute resolution and regularly provides legal advice to international pharmaceutical and tech companies on corporate, marketing authorization, intellectual property and labour law matters. In addition, he has extensive international litigation and arbitration experience.
Zoltán is the author of several publications. His academic articles have appeared in the journal “Gazdaság és Jog”, the Oxford Journal of Intellectual Property Law & Practice and the Kluwer Arbitration Blog, among others.
In 2018, he and his colleagues won the Wolters Kluwer Lawyers’ Award in the category of intellectual property law.
Dr. Tamás Palicz obtained his doctoral degree in medicine at the University of Debrecen in 1993, then in 1998 he became a specialist in internal medicine at the 3rd Department of Medicine of Semmelweis University. After several years of clinical practice he started to plan, implement and monitor EU-funded projects. He has been working as a manager since 2003, initially as Deputy Director General of the Directorate General for Strategy and Operational Development at Semmelweis University, and from 2005 as Medical Director of the Kútvölgy Clinic. Between 2010 and 2013, he was the Head of the Managing Authority for Human Resources Development and Renewal Operational Programs (TIOP and TÁMOP) of the National Development Agency, which was responsible for planning and monitoring the implementation of these projects. From 2013, he worked for two years as the Deputy Director General of the National Institute for Health Development and as the professional leader of the TÁMOP-612A-14/1-A project, where he was responsible for the introduction of school health promotion. Since the end of 2015, he is the Deputy Strategic Director at the Health Services Management Training Centre of Semmelweis University, where he earned his Masters's degree in Healthcare Management in 2001.
His main areas of interest are process-oriented management of healthcare organisations, leading organisational changes and project management in healthcare. In recent years, in the context of the digital transformation of healthcare, he has begun to address cybersecurity issues within healthcare organisations.
Istvan Petak, MD, Ph.D., is a physician and researcher. He has been developing technologies together with his team to find the best personalized, targeted therapy for cancer patients for over 20 years. His group was one of the pioneers of predictive molecular diagnostics. Their current development is a method to match the best, targeted therapy to each genetic alterations or combination of genetic changes in every cancer patient. This technique is being implemented into an artificial intelligence-based medical software system. This system and method received the award of the American Society Clinical Oncology at their Breakthrough Oncology conference in Bangkok, and it also won the innovation prize of the GET IN THE RING V4, in 2019. Dr. Petak is the founder and CEO of Oncompass Medicine and regular lecturer of the Semmelweis University, Budapest, and the University of Illinois at Chicago.
Balazs has been graduated at the Semmelweis Medical School in 1992, then he got a further MSc degree at the London School of Hygiene and Tropical Medicine & London School of Economics and Political Science, Public Health and Policy Health Care Management, where he has continued his further studies at the Health Services Research Unit. Furthermore he has also graduated at the Eötvös Lóránd Science University Faculty of Social Sciences Health Economics Task Force on Drug Policy and Pharmaceutical Economics. His work experience encompasses wide range of health care sector: He has served as a General Practitioner, managing a public health institution, worked at the Ministry of Health, World Bank Public health programs, and also used to be director at the Pharmaceutical sector, as well as Private Health Insurance, Health Fund. He is proud to be the founder of the first Hungarian private health insurance providing in-kind care, or establishing health fund, and also he has participated in the foundation of the first Hungarian Fund Holding primary care model. With his 12 colleagues he is managing a medical devices distributor firm, besides he is providing health economics, health care management, health policy advices to several health insurance companies, health care providers. He is also the health policy advisor of the Major of Budapest.
Jordan Rubinson has more than 20 years of experience in the pharmaceutical industry with large pharma companies like Pfizer, GlaxoSmithKline, and Aventis. He recently worked in early stage companies as a CEO of Regenera Pharma, as a Chief Commercial Officer for Champions Oncology, and was also the CEO of Polyheal Ltd, which was sold to TEVA at a $90M valuation. He worked at Pfizer as the marketing director for Israel, at GSK in U.S. marketing, and at GSK France, managing a large field force division of over 100 employees. While at Aventis, Jordan had assignments in France, Canada and the U.S. He holds an engineering degree from Columbia University and an MBA from MIT.
Bálint Szabó is head of division at the National Healthcare Service Center (ÁEEK). He graduated at Eötvös Lóránd University, Budapest Technology University and Kossuth Lajos University.
He is responsible for the establishment and operation of the National eHealth Infrastructure (EESZT), As the leader of the program aimed at establishing the future of e-health, he led the development of the EESZT, and now he leading its ongoing operation. This is solidly based on his professional background that includes experience in software development project management in various industries, as well as enterprise IT operation management. He regularly presents at IT conferences and he is the author of several professional publications.
Barnabás is an engineer-economist with extensive experience in the medical device and diagnostics field.
He graduated from the Budapest University of Technology as a mechanical engineer in 2003 and did his postgraduate studies at the Budapest Corvinus University.
He started his career at the Budapest University of Technology, where he was involved in an international cardiovascular stent research and development project.
In 2007 he began to work at MED-EL GmbH. in Austria as a development project lead in the implantable neurostimulation field.
In 2011 he joined the Hungarian In Vitro Diagnostic company 77 Elektronika Kft. as diabetes topic manager and became soon deputy director of the Development Department. His responsibility is cross-functional device development of multiple product lines from idea to market release in international environment, including quality and regulatory aspects. His main area is Point of Care Testing and related digital health technologies.
Barnabás is a strategic planner with a high focus on medical product related innovation.
He is married and father of 3 children.
Miklós Szócska, MD graduated at the Semmelweis University (SU) of Medicine in 1989. He holds a Master of Public Administration degree from the John F. Kennedy School of Government at Harvard University (1998), and a Ph.D. from the SU in the field of change management (2003). After his graduation at the SU he and his colleagues initiated the creation of the Health Services Management Training Centre (officially established in 1995). Between 1995 and 2000 he was serving as the deputy director and in 2000 he was appointed to be the director of the Centre. Between 2010-2014 Dr. Szócska served as the Minister of State for Health of the Hungarian Government. Since 2014 he serves again as the Director of HSMTC and became responsible for the Institute of Digital Health Sciences at SU. In 2016 He was nominated by the Hungarian Government for the DG position of the WHO. In July 2019 Dr Szócska was appointed to be the Dean of the Faculty of Health and Public Services at Semmelweis University.
Adapting to the characteristics of the Israeli ecosystem as the Science and Technology
Attaché of Hungary in Tel-Aviv he focuses on projects of applied research, experimental
development and startup cooperation. One of the flagship frameworks supporting the joint
RDI activities is the Hungary-Israel call for proposals in industrial research and development
published on annual basis. As a priority taks Mr. Szolnoki assists the interested companies in
searching partners. The areas of cooperation and interest mainly are: life sciences, digital
health, cybersecurity, mobility and autonomous vehicles, space-industry. Szabolcs Szolnoki is
a doctoral student at the University of Pécs, Insititute of Geography and Earth Sciences.
Before his diplomatic service he assisted innovative Hungarian inventors in starting their
businesses and entering domestic and foreign markets.
He graduated at the Budapest University of Economic Sciences and Public Administration as a financial investment analyst and risk manager in 2003. He has more than 12-years experience in venture capital and private equity investments, as well as, strategic and financial management of companies. Between 2003 and 2007 he worked for the Hungarian Development Bank (MFB) and MFB Invest Zrt. His position was investment analyst, he was responsible for the analysis of development plans, company valuation, the support of the operation of the portfolio companies, and the exit from the investments. He is working for Cashline Group since 2007 as a portfolio-manager, active in the deal flow generation, project analysis, valuation, management of the entire investment and exit process, as well as, strategic management of the portfolio companies. Since 2012 he is responsible for the venture capital activity of Cashline Group, and is the CEO of Valor Capital. He completed a Ph.D. Program at Corvinus University of Budapest, on the Department of Environmental Sciences and Technology in 2015. His research topics are environmental innovations and patents. He is managing director and board member of numerous Hungarian small and medium-sized enterprises.
He spent 4 years as trauma surgeon at Petz Aladár County Hospital in Győr. Since 1994 he is working in pharmaceuticals and medical device market in different positions, mainly with sales responsibilities. He joined Medtronic at 2011 as Business Manager lead the Diabetes Business Unit, which provides medical devices and technologies for diabetes management including insulin pump and continuous glucose monitoring. Medtronic plays key role in the innovation of diabetes management with products and technologies which priovides both effective diabetes management and improved quality of life. Telemedicine is part of its portfolio.
We in Roche Hungary work together to close the gap between the Hungarian and European patients` outcomes by building partnerships with patients and the healthcare system`s stakeholders, utilizing Roche`s portfolio and beyond. Irma is adding more than 25 years of experience in Commercial Pharmaceutical & Biotech markets; firstly in emerging markets and then in developed markets at both operational and strategic levels. She is a Master of Pharmacy by education, worked the majority of her career at the Slovenian Roche affiliate in several different positions, also as the General Manager until she was appointed General Manager of Roche Hungary in 2017.
In addition to his research in digital health, biotechnology and health economic evaluation, he is a lecturer of health economics and healthcare innovation for Hungarian and international students. Prior to his academic career, Zsombor has worked in child psychiatry, and then he spent 17 years in the pharmaceutical industry in various national and international roles including sales, medical, marketing and business unit management. He has worked in the European Brand Team of Pfizer from Hungary, Germany, the UK and France. At Egis Pharmaceuticals Plc. he led the launch of the first biosimilar monoclonal antibody in a number of countries in Eastern Europe and the CIS region. He graduated as a medical doctor at the Semmelweis University, and holds and MBA from the Oxford Brookes University as well as a PhD from the Corvinus University of Budapest.
Budapest Music Center
1093 Budapest, Mátyás street 8.